Tacrolimus Extended Release Formulation Given As An Alternative To Ciclosporine A In Case Of Renal Impairment After Allogeneic HSCT: Results From a Prospective Pilot Study
Marie Y. Detrait(Hôpital Civil de Charleroi), Fiorenza Barraco(Hôpital Lyon Sud), Vérane Schwiertz(Hospices Civils de Lyon), Valerie Chapel, Caroline Serrier(Hôpital Lyon Sud), Christiane Cazac(Hôpital Lyon Sud), Sothiny Sar(Hôpital Lyon Sud), Stéphane Morisset(Lyon 1 Université), Catherine Rioufol(Lyon 1 Université), Mauricette Michallet(Université Claude Bernard Lyon 1), Adrien Quintela(Hospices Civils de Lyon), Nicolas Vantard(Hospices Civils de Lyon), Florence Ranchon(Lyon 1 Université), M. Manchón, Sabine Cohen(Hospices Civils de Lyon)
Cited by 0
Related Papers
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
|The Lancet Haematology|2016|431
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
|Bone Marrow Transplantation|2015|387
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309